Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Swathi Karri"'
Autor:
Michael Green, Jingwei Liu, Zheng Zhang, Fuliang Chu, Sattva S Neelapu, Laura Bover, Ryan Sun, Jingjing Cao, Haopeng Yang, Timothy J Davis, Shao-qing Kuang, Xiaoyun Cheng, Swathi Karri, Long T Vien, Francisco Vega, Richard Eric Davis
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 11 (2023)
Background Chimeric antigen receptor (CAR) T cells targeting CD19 mediate potent and durable effects in B-cell malignancies. However, antigen loss or downregulation is a frequent cause of resistance. Here, we report development of a novel CAR T-cell
Externí odkaz:
https://doaj.org/article/d33413c6c13241c5b627404f177fbf5d
Autor:
Swathi Karri, Arijit Sur
Publikováno v:
Multimedia Tools and Applications. 74:9207-9230
Calibration attack is one of the most important attacks specially on JPEG domain steganography. Prediction of cover image statistics from its stego image is an important requirement in calibration based attacks. Domain separation techniques are used
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e9c0520c350ed7d3c01c523946c49ad
https://doi.org/10.1007/s11042-014-2077-0
https://doi.org/10.1007/s11042-014-2077-0
Autor:
Jingwei Liu, Sattva S. Neelapu, Fuliang Chu, Xiaoyun Cheng, Jinsheng Weng, JingJing Cao, Shao-Qing Kuang, Adithi Reddy, Swathi Karri
Publikováno v:
Blood. 132:1662-1662
Targeting CAR T resistance due to CD19 loss with CD79b-specific CAR T cells in B-cell malignancies Fuliang Chu, JingJing Cao, Jingwei Liu, Xiaoyun Cheng, Swathi Karri, Adithi Reddy, Shao Qing Kuang, Jinsheng Weng, Sattva S. Neelapu Department of Lymp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::172be263dd7e8dad6d1cb12ef643175c
https://doi.org/10.1182/blood-2018-99-119009
https://doi.org/10.1182/blood-2018-99-119009
Autor:
Sattva S. Neelapu, Fuliang Chu, Hiroki Torikai, Sourindra Maiti, Rohit Mathur, Zheng Zhang, R. Eric Davis, Laurence J.N. Cooper, Kelsey E. Moriarty, Deepshika Medapalli, Jinsheng Weng, Man Chun John Ma, Swathi Karri, Yong Pan, Xiaoyun Cheng
Publikováno v:
Blood. 132:3488-3488
Chimeric antigen receptor (CAR)-modified T-cell therapy targeting CD19 induces high response rates in patients with relapsed or refractory B-cell lymphomas. However, about 60% of patients experience primary or secondary resistance after CD19-targeted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e116893e254350b3848ba1454c294b71
https://doi.org/10.1182/blood-2018-99-115424
https://doi.org/10.1182/blood-2018-99-115424
Autor:
Yong Pan, Hua Wang, Fuliang Chu, Hiroki Torikai, Jinsheng Weng, Sourindra Maiti, Xiaoyun Cheng, Laurence J.N. Cooper, Sattva S. Neelapu, Kelsey E. Moriarty, Deepshika Medapalli, Flavio Egidio Baio, Swathi Karri
Publikováno v:
Cancer Research. 78:2566-2566
T-cell leukemia/lymphoma Antigen1 (TCL1) is a B-cell oncoprotein that is overexpressed in multiple forms of B-cell lymphoma. In our previous study, we identified a HLA*A0201-restricted T cell epitope from TCL1 that stimulated CD8+ T cells to specific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b57aa01eaa06668498c537cf38d6f7be
https://doi.org/10.1158/1538-7445.am2018-2566
https://doi.org/10.1158/1538-7445.am2018-2566